Published in Diabetes on September 01, 1983
Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med (1976) 2.72
Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest (1989) 2.69
Insulin independence after islet transplantation into type I diabetic patient. Diabetes (1990) 2.57
Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest (1980) 2.57
Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med (1980) 2.55
Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest (1993) 2.35
Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes (1991) 2.17
Perioperative management of surgical patients with diabetes mellitus. Anesthesiology (1991) 2.11
Pressure reversal of anaesthesia. Nature (1971) 2.10
Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med (1983) 1.83
Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes (1994) 1.81
The pressure reversal of general anesthesia and the critical volume hypothesis. Mol Pharmacol (1973) 1.79
The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA (1991) 1.74
Lipid in the aortic intima. The correlation of morphological and chemical characteristics. J Atheroscler Res (1967) 1.73
Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest (1980) 1.71
The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lipid Res (1974) 1.67
Norepinephrine: hormone and neurotransmitter in man. Am J Physiol (1978) 1.66
The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest (1976) 1.63
Insulin resistance in HIV protease inhibitor-associated diabetes. J Acquir Immune Defic Syndr (1999) 1.61
Plasmin, fibrin degradation and angiogenesis. Nat Med (1996) 1.59
Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J (1981) 1.54
Epidemiologic investigation of Marburg virus disease, Southern Africa, 1975. Am J Trop Med Hyg (1978) 1.54
Perceived symptoms in the recognition of hypoglycemia. Diabetes Care (1993) 1.53
Physicochemical approaches to the mode of action of general anesthetics. Anesthesiology (1972) 1.53
Isotope-derivative measurements of plasma norepinephrine and epinephrine in man. Diabetes (1976) 1.52
External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. J Lab Clin Med (1985) 1.52
Canine scabies in dogs and in humans. JAMA (1967) 1.52
Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. J Clin Endocrinol Metab (1980) 1.50
Human trypanosomiasis in Rhodesia. A new hypothesis suggested for the rarity of human trypanosomiasis. Cent Afr J Med (1968) 1.49
Elastoderma. J Am Acad Dermatol (1995) 1.47
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med (1985) 1.47
Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest (1987) 1.47
Retracted Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion. J Clin Invest (1986) 1.45
Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest (1987) 1.44
Adjuvant therapy of generalized peritonitis with intraperitoneally administered cephalothin. Surg Gynecol Obstet (1973) 1.42
Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture. J Clin Endocrinol Metab (1974) 1.37
Glucose counterregulation in man. Diabetes (1981) 1.36
The microdissection of large atherosclerotic plaques to give morphologically and topographically defined fractions for analysis. 1. The lipids in the isolated fractions. Atherosclerosis (1972) 1.32
Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol (1999) 1.31
Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number. J Clin Invest (1980) 1.29
Plasma catecholamines in diabetes. The syndromes of hypoadrenergic and hyperadrenergic postural hypotension. Am J Med (1978) 1.29
Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism (1980) 1.28
Ultrasonic imaging system for the study of decompression-induced gas bubbles. Undersea Biomed Res (1979) 1.26
Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med (1988) 1.25
Effect of stepped hypoglycemia on regional cerebral blood flow response to physiological brain activation. Am J Physiol (1996) 1.24
Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [l-13C]palmitic acid. J Clin Invest (1981) 1.24
Distribution of plasma proteins across the human aortic wall--barrier functions of endothelium and internal elastic lamina. Atherosclerosis (1980) 1.22
Hypoglycemia in compensated chronic renal insufficiency. Substrate limitation of gluconeogenesis. Diabetes (1974) 1.21
Iatrogenic injuries to extrahepatic ducts and associated vessels: a twenty-five-year analysis. J Natl Med Assoc (1982) 1.21
Glossopharyngeal neuralgia with syncope secondary to tumor. Treatment and pathophysiology. Am J Med (1981) 1.20
The chemical and immunological assay of low density lipoproteins extracted from human aortic intima. Atherosclerosis (1970) 1.16
Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav Neurosci (1993) 1.16
Resistance and serological changes in rabbits immunized with virulent Treponema pallidum sonicate. Acta Derm Venereol (1971) 1.15
Alternating choreoathetosis associated with uncontrolled diabetes mellitus and basal ganglia calcification. Diabetes Care (1986) 1.15
Regulation of growth hormone secretion in acromegaly. J Clin Endocrinol Metab (1969) 1.15
Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia). N Engl J Med (1984) 1.14
Congenital Absence of Abdominal Muscles and other Defects. Proc R Soc Med (1913) 1.13
The detection of gas bubbles in guinea-pigs after decompression from air saturation dives using ultrasonic imaging. J Physiol (1980) 1.13
Site of action of general anaesthetics. Nature (1965) 1.13
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes (2001) 1.13
Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes (1998) 1.11
Immunological studies on treponemal antigens. II. Serological changes and resistance to infection in rabbits immunized with culture supernatant of avirulent Treponema pallidum. Br J Vener Dis (1971) 1.08
Basal cell carcinoma does metastasize. Dermatol Online J (2008) 1.08
Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion. J Clin Invest (1983) 1.08
The physical urticarias. An update and review. Arch Dermatol (1982) 1.07
Topical clotrimazole in tinea pedis. South Med J (1977) 1.07
Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv Ment Dis (1986) 1.07
A Preliminary Communication on Syphilis and Mental Deficiency. Proc R Soc Med (1911) 1.06
Effect of onychomycosis on quality of life. J Am Acad Dermatol (1998) 1.06
Editorial: Foreign physicians in the United States. J Natl Med Assoc (1974) 1.06
Bacteriology of inflamed and uninflamed epidermal inclusion cysts. Arch Dermatol (1998) 1.06
Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry (1999) 1.05
Psychiatric disorder in medical in-patients. Q J Med (1987) 1.05
Nucleotide inhibition of adenyl cyclase activity in fat cell membranes. Biochim Biophys Acta (1969) 1.05
Adrenomedullary response to maximal stress in humans. Am J Med (1984) 1.04
Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man. Am J Physiol (1980) 1.04
Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J Pathol (1992) 1.04
Blood glucose regulates the effects of insulin and counterregulatory hormones on glucose production in vivo. Diabetes (1979) 1.04